Journal Contents :   №25 3 2023

Original investigations

EXPRESSION PROFILE OF SOME MARKERS OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA

№25 3 2023 27

THE SIGNIFICANCE OF THE EXPRESSION OF THE EPITHELIAL-MESENCHYMAL TRANSITION MARKER SNAIL1 AND ITS REGULATOR TGF-β1 IN THE PROGRESSION OF ENDOMETRIOID CARCINOMA OF THE ENDOMETRY

№25 3 2023 29

VIOLATION OF THE REDOX BALANCE IN NON-MALIGNANT CELLS OF PRIMARY ONCOGYNECOLOGICAL PATIENTS

№25 3 2023 19

IDENTIFICATION AND FUNCTIONAL ANALYSIS OF microRNA AS PROSPECTIVE PROGNOSTIC MARKERS OF COLORECTAL CANCER

№25 3 2023 14

TUMOR MICROENVIRONMENT AND BODY MASS INDEX: CORRELATION WITH THE PROGRESSION OF GASTRIC CANCER

№25 3 2023 16

OPTIMISING THE TREATMENT OF PATIENTS WITH ADVANCED OVARIAN CANCER: AN ANALYSIS OF PRELIMINARY RESULTS

№25 3 2023 28

EVALUATION OF CD38 ANTIGEN EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: THE EXPERIENCE OF CLINICAL IMMUNOLOGY DEPARTMENT, NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE, NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE

№25 3 2023 26

THE INFLUENCE OF SPERMINE AND CHLORHEXIDINE ON THE SURVIVAL, ELECTROKINETIC AND CYTOMORPHOLOGICAL CHARACTERISTICS OF HUMAN PROSTATE CANCER CELLS

№25 3 2023 37

Opinion

B-CELL LYMPHOID NEOPLASMS IN THE 5TH EDITION OF THE WHO CLASSIFICATION OF HEMATOLYMPHOID TUMORS (2022). 2. Mature B-cell neoplasms, plasma cell neoplasms and other diseases with paraproteins

№25 3 2023 26

Official information

ANNIVERSARY DAYS OF ONCOLOGY IN PARIS

№25 3 2023 17

Exchange of experience

ALGORITHM OF PREOPERATIVE EXAMINATION AND METHODS OF SURGICAL TREATMENT OF PATIENTS WITH LOCALIZED KIDNEY CANCER

№25 3 2023 15